Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 10415060)

Published in J Immunol on August 01, 1999

Authors

H E Thomas1, R Darwiche, J A Corbett, T W Kay

Author Affiliations

1: Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

Articles citing this

IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest (2000) 1.06

Islet beta-cells deficient in Bcl-xL develop but are abnormally sensitive to apoptotic stimuli. Diabetes (2009) 1.06

Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically. Am J Pathol (2007) 0.96

mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell. Diabetes (2010) 0.86

In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18. Eur J Immunol (2011) 0.85

A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res (2011) 0.82

Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. Am J Pathol (2011) 0.81

Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines. Biol Proced Online (2005) 0.79

Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death. Rev Diabet Stud (2006) 0.76

GAD65-Specific Cytotoxic T Lymphocytes Mediate Beta-Cell Death and Loss of Function. Rev Diabet Stud (2009) 0.75

Expansion of FasL-Expressing CD5(+) B Cells in Type 1 Diabetes Patients. Front Immunol (2017) 0.75

Protein kinase C-δ isoform mediates lysosome labilization in DNA damage-induced apoptosis. Int J Oncol (2010) 0.75

TOSO promotes β-cell proliferation and protects from apoptosis. Mol Metab (2012) 0.75

Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes. Front Immunol (2017) 0.75

Articles by these authors

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 11.96

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell (1999) 4.29

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00

Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med (2001) 2.60

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest (1991) 2.07

Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell (2000) 1.96

Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol (1994) 1.63

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 1.59

Lymphocytopenia in a hospital population--what does it signify? Aust N Z J Med (1997) 1.57

Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci (1997) 1.57

Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci (1994) 1.53

IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest (1998) 1.46

International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes (2001) 1.42

Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes (2000) 1.38

The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 1.33

Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31

Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J (2000) 1.29

Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med (1996) 1.29

Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun (1993) 1.29

Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem (1997) 1.25

Heel ulcers in patients with long-standing diabetes who wear antiembolism stockings. Med J Aust (1986) 1.21

Tics and Gilles de la Tourette's syndrome: a follow-up study and critical review. Br J Psychiatry (1969) 1.16

Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol (1998) 1.14

Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol. Br J Psychiatry (1967) 1.14

Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation. J Biol Chem (1998) 1.12

Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest (1998) 1.11

Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A (1994) 1.09

Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol (2001) 1.08

Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology (1995) 1.07

Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010. Am J Transplant (2014) 1.04

Comparison of Streptococcus mutans concentrations in non-banded and banded orthodontic patients. J Dent Res (1981) 1.03

Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes. J Biol Chem (2000) 1.01

Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans. J Biol Chem (1999) 1.00

Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol (1996) 0.98

Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett (1993) 0.98

Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology (1997) 0.97

Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process. J Clin Invest (1993) 0.97

Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol (2000) 0.97

Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. J Ment Defic Res (1990) 0.96

Glucose-induced insulin secretion from purified beta-cells. A role for modulation of Ca2+ influx by cAMP- and protein kinase C-dependent signal transduction pathways. J Biol Chem (1993) 0.96

Relative sensitivity of fetal and newborn mice to induction of hapten-specific B cell tolerance. J Exp Med (1980) 0.95

The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol (1998) 0.95

Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells. Endocrinology (1999) 0.95

Mechanisms of clonal abortion tolerogenesis. IV. Verification of the hypothesis in living mice. J Immunol (1980) 0.94

Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology (2001) 0.94

Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Endocrinology (1998) 0.94

Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism. J Biol Chem (1996) 0.94

Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Biochim Biophys Acta (1996) 0.93

Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab Res Rev (2000) 0.92

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscul Disord (2013) 0.92

Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes (2000) 0.92

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant (2013) 0.91

Expression of carbonic anhydrase V in pancreatic beta cells suggests role for mitochondrial carbonic anhydrase in insulin secretion. J Biol Chem (1998) 0.91

Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets. Mol Pharmacol (1997) 0.90

Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int Immunol (1995) 0.90

Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum (1997) 0.89

Nitric oxide production by the rat insulinoma cell line, RINm5F, Is specific for IL-1: a spectrophotometric IL-1 bioassay. Anal Biochem (1996) 0.89

A role for nitric oxide and other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunction and destruction. Adv Exp Med Biol (1997) 0.86

A transgenic model to study the pathogenesis of somatic mtDNA mutation accumulation in beta-cells. Diabetes Obes Metab (2007) 0.86

Adoptive transfer of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2000) 0.86

Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol (1989) 0.86

Self-injurious behaviour in people with mental handicap: a total population study. J Ment Defic Res (1987) 0.86

Gonadotropin-releasing hormone stimulates glycoprotein hormone alpha-subunit messenger ribonucleic acid (mRNA) levels in alpha T3 cells by increasing transcription and mRNA stability. Endocrinology (1994) 0.85

Novel cyclic adenosine 3',5'-monophosphate response element in the human chorionic gonadotropin beta-subunit gene. Mol Endocrinol (1991) 0.85

Pervasive developmental disorders and psychoses in adult life. Br J Psychiatry (1989) 0.84

Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes (1998) 0.84

Worsening of pica as a symptom of depressive illness in a person with severe mental handicap. Br J Psychiatry (1993) 0.84

Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N-methyl-D-aspartate neurotoxicity. Brain Res (1993) 0.84

Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem (1996) 0.84

Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community. J Ment Defic Res (1990) 0.84

Cell fractionation methods and the target cells for clonal abortion of B lymphocytes. Immunol Rev (1979) 0.84

Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB. J Autoimmun (1997) 0.84

64,000-Mr autoantigen in type I diabetes. Evidence against its surface location on human islets. Diabetes (1987) 0.83

Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol Med (1998) 0.83

Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide. J Biol Chem (1999) 0.83

Aerosol addiction. Br J Psychiatry (1990) 0.83

Folic acid and mental symptoms in children with epilepsy. J Neurol Neurosurg Psychiatry (1980) 0.82

Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets. Diabetes (2001) 0.82

Localization of promoter sequences required for thyrotropin-releasing hormone and thyroid hormone responsiveness of the glycoprotein hormone alpha-gene in primary cultures of rat pituitary cells. Mol Endocrinol (1993) 0.82

gamma-Interferon signaling in pancreatic beta-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1. Diabetes (2001) 0.82

How beta cells die in type 1 diabetes. Curr Dir Autoimmun (2001) 0.82

Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes (1996) 0.81

Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes (1994) 0.81

Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes. J Neurochem (2001) 0.80

Deletion of chromosome 2 (p11-p13): case report and review. J Med Genet (1993) 0.80

Clinical and serological associations of anti-Ku antibody. J Rheumatol (1999) 0.79

Lack of expression of Gp-130 makes pancreatic beta cell lines unresponsive to the IL-6 family of cytokines. Int J Exp Diabetes Res (2001) 0.78

Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. Am J Physiol (1997) 0.78

Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome. Psychol Med (1996) 0.78

Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans. Biochim Biophys Acta (1997) 0.77

CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway. Transplantation (1999) 0.77

Behçet's disease with cerebral vasculitis. Intern Med J (2001) 0.77

Characterization of NADPH diaphorase activity in rat sympathetic autonomic ganglia--effect of diabetes and aging. Brain Res (1993) 0.77

Interferon regulatory factor 1 is induced by interferon-gamma equally in neurons and glial cells. J Neuroimmunol (1997) 0.76